| Literature DB >> 30792593 |
Prashanth Murthy1, Deborah Clark1.
Abstract
Neonatal abstinence syndrome (NAS) secondary to maternal drug use is a well-recognized clinical entity. We present a novel case of moderately severe NAS in a term infant whose mother was self-medicating with kratom tea. The baby required oral morphine for NAS. After 12 days in neonatal intensive care unit, she was discharged on oral morphine which was discontinued after 2 months. Kratom, a psychoactive herb with opioid activity, has traditionally been used as a stimulant to boost energy, cure cough, depression, pain, sickness and a substitute for opium. Although well known in South East Asia and Africa, this drug is less familiar to physicians in North America. It is undetectable by standard urine drug screening and is being sold as a legal herbal remedy. This is the first report of a newborn developing significant NAS after maternal use of kratom tea. We believe physicians should be aware of this 'new' risk to newborns.Entities:
Keywords: Kratom tea; Neonatal abstinence syndrome; Newborn
Year: 2018 PMID: 30792593 PMCID: PMC6376302 DOI: 10.1093/pch/pxy084
Source DB: PubMed Journal: Paediatr Child Health ISSN: 1205-7088 Impact factor: 2.253